A01=Walter Glannon
Author_Walter Glannon
bioethics
BRCA2 Gene
BRCA2 Mutation
Category=QD
cell
Cloned Child
cloning ethics
decent
Decent Minimum Level
Distant Future People
DNA Molecule
donor
Donor Cell Nucleus
Early Fetal Stage
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
ES Cell
ethical implications genetic modification
evolutionary biology
gene
Gene Therapy
genetic
Genetic Enhancement
Genetic Intervention
Human Life Span
intervention
IVF Embryo
Late Onset Genetic Disease
level
Mechanisms Controlling Blood Pressure
metaphysics of identity
minimum
moral responsibility genetics
National Academy
Negative Eugenics
Positive Eugenics
Presymptomatic Genetic Testing
Psychological Connectedness
reproductive technologies
SCID
Sense DNA Damage
Severe Combined Immune Deficiency
somatic
Somatic Cell Gene Therapy
therapy
Product details
- ISBN 9780367315948
- Weight: 453g
- Dimensions: 152 x 229mm
- Publication Date: 28 Aug 2019
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
Advances in genetic technology in general and medical genetics in particular will enable us to intervene in the process of human biological development which extends from zygotes and embryos to people. This will allow us to control to a great extent the identities and the length and quality of the lives of people who already exist, as well as those
Walter Glannon received a BA from Duke University, a Ph.D. in Spanish Literature from the Johns Hopkins University, and a Ph.D. in philosophy from Yale University. He has been a Killam Post-doctoral Fellow at the Centre for Applied Ethics, University of British Columbia, a Fellow at the Institute for Ethics of the American Medical Association, and a Fellow at the MacLean centre for Clinical Medical Ethics, University of Chicago. He is Assistant Professor in the Biomedical Ethics Unit, Faculty of Medicine, McGill University and Clinical Ethicist at the Jewish General Hospital, Montreal.
